Log in to save to my catalogue

Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regul...

Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regul...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A827876917

Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model

About this item

Full title

Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model

Publisher

BioMed Central Ltd

Journal title

Lipids in health and disease, 2025-02, Vol.24 (1)

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease worldwide. Previous studies have reported that fucoidan can relieve obesity and hepatic steatosis in vivo, although the molecular mechanism remains unclear. This study aimed to explore the effect and potential molecular mechanism of fucoidan in NAFLD us...

Alternative Titles

Full title

Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A827876917

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A827876917

Other Identifiers

ISSN

1476-511X

E-ISSN

1476-511X

DOI

10.1186/s12944-025-02483-z

How to access this item